- Open Access
Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses
© The Author(s). 2016
- Received: 3 March 2016
- Accepted: 23 June 2016
- Published: 1 July 2016
The length of time for cigarette smoke (CS) exposure to cause emphysema in mice is drastically reduced when CS exposure is combined with viral infection. However, the extent of inflammatory responses and lung pathologies of mice exposed to CS and infected with influenza A virus (IAV), respiratory syncytial virus (RSV), or treated with the viral derivative dsRNA (polyinosine-polycytidylic acid [poly (I:C)] have not been compared.
Mice were exposed to CS or filtered air for 4 weeks and received a single dose of vehicle, AV, or RSV infection and extent of inflammation and emphysema was evaluated 14 d later. In another set of experiments, mice were instilled with poly (I:C) twice a week during the third and fourth weeks of CS exposure and immediately analyzed for extent of inflammation and lung pathologies.
In CS-exposed mice, inflammation was characterized mainly by macrophages, lymphocytes, and neutrophils after IAV infection, mainly by lymphocytes, and neutrophils after RSV infection, and mainly by lymphocytes and neutrophils after poly (I:C) instillations. Despite increased inflammation, extent of emphysema by poly (I:C) was very mild; but was robust and similar for both IAV and RSV infections with enhanced MMP-12 mRNA expression and TUNEL positivity. Both IAV and RSV infections increased the levels of IL-17, IL-1β, IL-12b, IL-18, IL-23a, Ccl-2, Ccl-7 mRNAs in the lungs of CS-exposed mice with IAV causing more increases than RSV.
CS-induced inflammatory responses and extent of emphysematous changes differ depending on the type of viral infection. These animal models may be useful to study the mechanisms by which different viruses exacerbate CS-induced inflammation and emphysema.
- Influenza A virus
- Respiratory syncytial virus
- Poly (I:C)
- Cigarette smoke
Chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis, is the third leading cause of death in the US . COPD refers to a broad group of lung diseases with airflow limitation, parenchymal destruction, fibrosis around small airways involving several different cells (neutrophils, macrophage, CD8 lymphocytes) [2, 3], and small-airway obstruction . The most studied of these conditions is emphysema, which is characterized by permanent inflammation and irreversible destruction of alveolar walls, leading to airspace enlargement and loss of elastic recoil and hyperinflation . Exposure to CS accounts for about 80 % of all COPD cases [6–9], but other factors when combined with cigarette smoke play a role in exacerbating CS-induced COPD [10, 11]. Repeated incidences of COPD exacerbations are associated with more rapid disease progression, poorer quality of life, and higher risk of mortality [12, 13]. Environmental pollutants, including wood smoke [10, 14, 15–17] and diesel exhaust  play a role in enhancing CS-induced inflammation. Bacterial and viral infections are also major causes for COPD exacerbations [19–25] leading to decline in lung function and concomitant acute deterioration in respiratory health . Interestingly, as many as 40 to 60 % of all exacerbations are attributed to respiratory viral infections alone [26, 27].
Interactions between CS exposure and viral infection induce exaggerated inflammatory and tissue remodeling responses [28, 29]. Viral infections, such as IAV [30–32] and respiratory syncytial virus (RSV) [19, 24, 25] are associated with acute COPD exacerbations, but the severity of infection in patients with COPD depends on both viral and host factors . For example, RSV accounts for a quarter of all viral-induced COPD exacerbations [19, 24, 25] and is an important respiratory pathogen in the elderly, particularly in those with chronic lung diseases such as COPD [23–25]. Approximately 60 million people currently smoke cigarettes in the US alone, and many of the immunocompromised elderly individuals are susceptible to RSV infections and will have recurrent seasonal flu infections. To understand disease progression and develop better therapies, establishing animal models that reflect these conditions in humans is crucial.
While the development of emphysema in mice requires an exposure to CS for 4–8 months [34–38], infection with respiratory viruses enhances CS-induced inflammation and causes emphysema within 6 weeks .
The purpose of the current study was to establish mouse models that recapitulate the cardinal features of COPD within a short period of time by comparing extent of inflammation and emphysema after a 4 week CS exposure in combination with a single infection of either IAV, RSV, or multiple instillation with Poly(I:C). We show that such a 2-hit system enhances lung inflammation and the development of emphysema. Despite these similarities, these animal models also showed major differences in the type and extent of inflammation and alveolar destruction.
Cigarette smoke exposure and virus infection
Lung inflammatory cells, histology and morphometry
Mice were euthanized by lethal injection of pentobarbital sodium followed by exsanguination. Lung inflammatory cells were recovered by bronchoalveolar lavage (BAL) and total recovered cells were counted in BAL fluid (BALF) and immune cell types in the BALF were quantified after staining cytospins using a Diff-quik kit (Siemens Healthcare Diagnostics, Inc., Newark, DE) per manufacturer’s direction. For lung histology and morphometry, lungs were inflated and fixed with 4 % buffered paraformaldehyde at a constant hydrostatic pressure of 25 cm for 4 h and further immersed in fixative for 48 h. The inflated lungs were embedded in paraffin and 5 μm sagittal sections were stained with hematoxylin and eosin (H&E) for histological evaluation as described . To analyze inflammation-associated lung damages, H&E–stained lung tissues were evaluated in a blinded manner with a semi-quantitative system according to the relative degree of inflammation and tissue damage. Inflammatory changes were evaluated and described by a board certified pathologist. Lung inflammatory changes were graded based on the following parameters: peri-bronchiolar and bronchial infiltrates, bronchiolar and bronchial luminal exudates, perivascular infiltrates, parenchymal pneumonia, and edema, as previously described [43–46]. Each parameter was graded on a scale of 0–4 with 0, absent; 1, slight; 2, mild; 3, moderate; and 4, severe. The cumulative scores of inflammatory infiltration, degeneration and necrosis provided the total score per animal, and the average score of mice in each group was taken as total score for that group. Morphometric analysis of alveolar volume measurement was carried out using the Visiomorph module of VisioPharm analysis software (Visiopharm, Hoersholm, Denmark).
We analyzed fixed lung tissues from each group for cells with internucleosomal DNA fragmentation using the TUNEL assay, as described elsewhere [47, 48]. Briefly, terminal deoxynucleotidyltransferase was used to incorporate biotin-16-dUTP into the ends of DNA fragments. For lung tissues from each group with internucleosomal DNA fragmentation TUNEL signals were visualized using the Vectastain avidin-biotin complex kit and the peroxidase substrate diaminobenzidine (Vector Laboratories, Burlingame, CA) and microscopy (Zeiss) as described by the manufacturer.
Analysis of mRNA levels
Total RNA was isolated from snap-frozen lung tissue using the RNeasy mini kit (Qiagen, Valencia, CA) which included a 10 min on-column DNAse treatment. Mouse IL17 RT2 Profiler PCR array (SA Biosciences, Valencia, CA) was used to analyze host gene expression on samples from lungs of mice exposed to FA or CS and infected with IAV or RSV. SA Biosciences web based RT2 profiler PCR array data analysis program was used to calculate fold changes. Quantitative TaqMan RT-PCR was performed following manufacturer’s instructions (Applied Biosystems, Foster City, CA) to measure mRNA levels for IL-17a, IL-17c, IL-17d, IL-17 f. IL-1β, IL-12b, IL-18, IL-23a, Ccl-2, Ccl-7 at day 4 post infection in lung tissue samples from Vehicle- or IAV- or RSV-infected mice exposed to FA or CS. Quantitative RT-PCR analysis for MMP-12 mRNA was performed at day 14 post infection. Viral load was evaluated by quantitative RT-PCR using TaqMan primer and probe that detects IAV M and RSV NS1 gene mRNAs. RT-PCR was performed in an ABI Prism 7900 Sequence Detection System (Applied Biosystems) using universal thermal cycling parameters. Gene expression was analyzed using the comparative CT method after normalization to GAPDH of Vehicle infected, C-exposed mice.
Data were analyzed and graphed using GraphPad PRISM version 5.04. Data were generally analyzed using one-way ANOVA, and when significance was detected, the Fisher’s exact least significant difference test was used to determine differences between groups. Body weight comparisons were analyzed using ANOVA with repeated measures, followed by a post hoc Fisher’s least significance difference test. Viral titres in the lung were compared using an unpaired Student’s two-tailed t-test. Comparisons of inflammatory cells, weighted mean alveolar volume, mean linear intercepts, inflammation scores, MMP-12 RNA levels and TUNEL positivity among groups were analyzed using ANOVA followed by Tukey’s Multiple Comparison Test. Unless otherwise stated data are presented as mean +/− standard error of mean (SEM) for at least 6 mice/group. Probability values less than 0.05 were considered significant.
Lung inflammation in CS-exposed mice when infected with IAV and RSV
Infection with IAV or RSV leads to the development of emphysema in CS-exposed lung
IAV and RSV infections increase the expression of IL-17 and its upstream regulators
IAV and RSV alter cigarette smoke induced lung cytokine mRNA expression
IAV and RSV infections enhance the expression of MMP-12 in cigarette smoke-injured lung
Apoptosis plays an important role in the development of emphysema [52–54]. Analyses for internucleosomal DNA fragmentation using the TUNEL assay showed that neither IAV nor RSV infection alone caused significant increase in TUNEL positivity in FA-exposed group. Compared to FA-exposed mice, CS-exposed mice had significant increase in TUNEL positivity in the lung tissues and these increases were further enhanced equally by both IAV (Fig. 8c) and RSV infection (Fig. 8d).
The present study utilized mouse models with existing CS exposure to compare extent of inflammatory responses and tissue destruction when infected with IAV, RSV, or instilled with Poly (I:C). When comparing these three models, one needs to consider the differences in the viral titers for IAV and RSV used to infect the mice. In addition, multiple doses of Poly (I:C) were delivered to mice over the last two weeks of CS exposure, and mice were euthanized right after 4 weeks of exposure to CS and were not kept for an additional 14 days in FA as in the cases with IAV and RSV groups. Repeated administration was chosen to compensate for the lack of replication in the poly(I:C) group.
We found that by day 4 post infection CS-exposed groups had significantly lower copy number of viruses than the FA groups for both IAV and RSV study groups. This may be due to early induction of type I IFN by cigarette smoke [28, 55], which may suppress virus replication. As inflammation progresses, IFN response may wane resulting in delayed viral clearance and more titer in CS-injured lungs than FA-exposed lungs on day 14 post infection.
While the overall total numbers of inflammatory cells recovered in the BAL of CS-IAV/RSV and CS-poly(I:C) mice were synergistically increased, differences in the type and degree of inflammatory responses were observed among these groups. The CS-IAV group displayed increased number of macrophages and lymphocytes with few neutrophils, and CS-RSV group showed increased lymphocytes and neutrophils, similar to that observed in the CS-poly(I:C) group. These findings are consistent with previous studies showing that IAV or poly (I:C) lead to additive effects in the level of BAL inflammatory cells in mice exposed to CS [28, 56]. Interestingly, despite higher titers used for RSV, IAV caused more inflammation suggesting that different viruses have distinct inflammatory patterns either alone or when combined with CS exposure. Macrophages and neutrophils are the main sources of proteases in lungs, and there are correlations between the degree of macrophage and neutrophil inflammation and severity of airflow obstruction . Although significant increases in the BAL neutrophils were observed among the models tested, poly (I:C) caused the mildest form of emphysema in CS-exposed mice. For the poly(I:C) group, emphysema measures were assessed at 4 weeks of CS exposure while the IAV and IAV groups of mice were assessed 14 d later. Further, IAV or RSV alone did not cause increases in alveolar spaces compared to their respective vehicle controls. Hence, it is possible that the poly(I:C) group could develop more pronounced structural changes in CS-exposed mice similar to the virally challenged groups given the appropriate time for the changes to develop. Emphysema that develops in mice after 6 months of exposure remains pronounced even 6 months later , and future studies will need to examine the persistence of the observed emphysematous changes several months after the initial infections.
Both IAV and RSV infection induced IL-17a, IL-17b, IL-17d, and IL-17f, IL-1β, IL-12b, IL-18, IL-23, Ccl-2, and Ccl-7 mRNA levels in the lungs of CS-injured mice. CD8+ T-lymphocytes are critical for the induction of inflammation and tissue destruction in a murine model of smoke-induced emphysema . CD4+ T cells, upon activation and expansion, develop into different T helper cell subsets with different cytokine profiles and distinct effector functions . Thus, IAV or RSV in CS-exposed mice may cause the differentiation of Th17 cells or may affect γδ T cells, NK cells, and neutrophils to produce IL-17 in response to CS exposure dependent induction of IL-1β, IL-18, or IL-23 . Despite higher titer for RSV, IAV was more potent in increasing expression of IL-17a, IL-17c, IL-12b, IL-18, IL-23a, IL-1β, Ccl-2, and Ccl-7 than RSV. It is possible that cytokine expression was also increased in the poly(I:C) group, but emphysematous changes were not apparent. Although we did not compare cytokine in the lungs of this group of mice with the RSV and IAV groups, a study using CS-poly(I:C) mouse model showed that poly(I:C) was a potent stimulator of IL-18, IL-12/IL-23 p40, and type I and type II IFNs with significantly greater responses in mice exposed to CS compared with mice in FA. This study suggest that IL-18Rα and IFN-γ play critical role in the pathogenesis of the inflammation and remodeling that is induced by CS plus poly(I:C). IAV [43, 61] and RSV  have been shown to induce Th17-related cytokines. Future studies will elucidate the specific roles of the different cytokines and chemokines in IAV- or RSV-infected or poly(I:C) treated mice exposed to CS.
In mice, IL-17 is essential for the development of emphysema from long term CS exposure  by activating the IL-17 → Ccl-2 → MMP-9 → MMP-12 signaling axis . Increases in IL-17-regulated genes and chemokines such as Ccl-2 and Ccl-7 are associated with COPD progression in humans [63–65]. This is consistent with our data showing that increased IL-17 expression was associated with increased expression of MMP-12 mRNA levels. Mouse models with MMP-12-deficient macrophages [51, 66] and pharmacological inhibition of MMP-12  showed that MMP-12 activity plays an important role in the development of emphysema.
It has long been believed that, in cigarette smoke–induced COPD, the alveolar destruction and enlargement is a direct consequence of inflammation and the associated imbalance in the extracellular matrix protease and antiprotease response, which leads to degradation of the elastin . However, despite differences in inflammatory responses, IAV and RSV infections led to similar extent of emphysema in the CS-exposed mice. Further, IAV and RSV infections significantly enhanced TUNEL positivity and upregulation of the MMP-12 mRNA to a similar extent. Also, despite increases in inflammation by poly (I:C) similar to RSV, extent of emphysema caused by poly (I:C) was milder. These findings suggests that inflammation does not necessarily correlate with lung pathology as was shown for CS-induced emphysema in C3H and C57Bl/6 mice . It is also possible that regardless of extent of lung inflammation, the severity of alveolar destruction and airspace enlargement in mice remains mild , likely because of lung structure or length of chronic inflammation. While infection with RSV leads to differentiation of Th17 cells [62, 68] and is associated with skewing the immune system away from the Th1 response , poly (I:C) may cause more Th1 than Th17 differentiation [70, 71]. Furthermore, although poly (I:C) activates TLR3 , repeated doses of poly (I:C) induce inflammation and alveolar remodeling via pathways independent of TLR3 . Future studies will investigate the role of innate versus Th17 immunity in the pathogenesis of IAV-, RSV-, and poly (I:C)-induced lung inflammation in CS-exposed mice.
Both weighted mean alveolar volume and Lm are useful parameters of peripheral lung structure and have utility in studying experimental emphysema [73, 74]. However, Lm reflects the dimensions of alveoli but is not a direct estimate of alveolar diameter or mean alveolar size. Although weighted mean alveolar volume, Lm, and indexes of lung elasticity are correlated in excised non-diseased lungs of humans  and several animal species  Lm may not be the most accurate measure. Lm is a function of lung volume [76, 77] but may not be able to separate the effects of tissue destruction from those on tissue distension and from any changes in lung elasticity that results in changes in lung volume, as would be expected with emphysema. Thus, conclusions drawn from Lm alone should be interpreted with caution.
Our studies demonstrate that IAV, RSV or poly (I:C) augment CS-induced airway and alveolar inflammation and remodeling in the murine lung. This study affirms that both RSV and IAV are key etiological factors driving cytokine, protease, and apoptotic responses that lead to airspace enlargements. However, there were significant differences in the type and extent of inflammation involved. The minimal emphysematous changes in the poly(I:C) group, compared to the CS-IAV and CS-RSV group, may be attributed to the differences in the study design and the shorter time elapsed between exposure to CS and analyses of the lung tissues. Future studies should elucidate the cause-effect relationships between inflammation and alveolar destruction in detail to dissect differences between these models to help translate these findings to patients with COPD exacerbations.
BAL, broncho-alveolar lavage; COPD, chronic obstructive pulmonary disease; CS, cigarette smoke; ES&H, Environmental Safety and Health department; FA, filtered air; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; H&E, hematoxylin and eosin; IACUC, Institutional Animal Care and Use Committee; IAV, Influenza A Virus; Lm, mean linear intercept; mRNA, messenger ribonucleic acid; PCR, polymerase chain reaction; Poly(I:C), polyinosine-polycytidylic acid; RSV, respiratory syncytial virus; RT-PCR, reverse transcriptase polymerase chain reaction; SEM, standard error of the mean; TPM, total particulate matter; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.
The authors thank Ms. Lois Herrera for technical assistance, Dr. Julie Hutt for evaluating and describing the lung pathologies, and Mrs. Elise Calvillo for helping with preparation of graphics and images.
Design and conception of study-YAM, KRS and YT; conducting of experiments-YAM, KRS, GEA; analysis and interpretation- YAM, KSRS, GEA, YT and drafting of manuscript for intellectual content-YAM, KRS, GEA, YT. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Minino AM, Xu J, Kochanek KD. Deaths: preliminary data for 2008. Natl Vital Stat Rep. 2010;59:1–52.PubMedGoogle Scholar
- Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645–53.View ArticlePubMedGoogle Scholar
- Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173:1114–21.View ArticlePubMedGoogle Scholar
- McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365:1567–75.View ArticlePubMedPubMed CentralGoogle Scholar
- Snider GL. Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Am Rev Respir Dis. 1989;140:S3–8.View ArticlePubMedGoogle Scholar
- Jinot J, Bayard S. Respiratory health effects of passive smoking: EPA’s weight-of-evidence analysis. J Clin Epidemiol. 1994;47:339–49. discussion 351–333.View ArticlePubMedGoogle Scholar
- Borchers MT, Kratzer A, Taraseviciene-Stewart L. Second hand smoke and COPD: lessons from animal studies. Front Physiol. 2014;5:144.View ArticlePubMedPubMed CentralGoogle Scholar
- Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73.View ArticlePubMedGoogle Scholar
- Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370:741–50.View ArticlePubMedGoogle Scholar
- Sood A, Petersen H, Blanchette CM, Meek P, Picchi MA, Belinsky SA, Tesfaigzi Y. Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. Am J Respir Crit Care Med. 2010;182:1098–104.View ArticlePubMedPubMed CentralGoogle Scholar
- Awji EG, Seagrave JC, Tesfaigzi Y. Correlation of Cigarette Smoke-Induced Pulmonary Inflammation and Emphysema in C3H and C57Bl/6 Mice. Toxicol Sci. 2015;147:75–83.View ArticlePubMedGoogle Scholar
- Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117:398S–401S.View ArticlePubMedGoogle Scholar
- Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418–22.View ArticlePubMedGoogle Scholar
- Guarnieri MJ, Diaz JV, Basu C, Diaz A, Pope D, Smith KR, et al. Effects of woodsmoke exposure on airway inflammation in rural Guatemalan women. PLoS One. 2014;9. e88455.Google Scholar
- Eisner MD, Yelin EH, Katz PP, Earnest G, Blanc PD. Exposure to indoor combustion and adult asthma outcomes: environmental tobacco smoke, gas stoves, and woodsmoke. Thorax. 2002;57:973–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Awji EG, Chand H, Bruse S, Smith KR, Colby JK, Mebratu Y, Levy BD, Tesfaigzi Y. Wood smoke enhances cigarette smoke-induced inflammation by inducing the aryl hydrocarbon receptor repressor in airway epithelial cells. Am J Respir Cell Mol Biol. 2015;52:377–86.View ArticlePubMedPubMed CentralGoogle Scholar
- Hawley B, Volckens J. Proinflammatory effects of cookstove emissions on human bronchial epithelial cells. Indoor Air. 2013;23:4–13.View ArticlePubMedGoogle Scholar
- Xia M, Viera-Hutchins L, Garcia-Lloret M, Noval Rivas M, Wise P, McGhee SA, Chatila ZK, Daher N, Sioutas C, Chatila TA. Vehicular exhaust particles promote allergic airway inflammation through an aryl hydrocarbon receptor-notch signaling cascade. J Allergy Clin Immunol. 2015;136:441–53.View ArticlePubMedGoogle Scholar
- Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359:2355–65.View ArticlePubMedGoogle Scholar
- Anzueto A, Sethi S, Martinez FJ. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4:554–64.View ArticlePubMedGoogle Scholar
- Papi A, Luppi F, Franco F, Fabbri LM. Pathophysiology of exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3:245–51.View ArticlePubMedGoogle Scholar
- Wedzicha JA, Hurst JR. Structural and functional co-conspirators in chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc. 2007;4:602–5.View ArticlePubMedGoogle Scholar
- Sikkel MB, Quint JK, Mallia P, Wedzicha JA, Johnston SL. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr Infect Dis J. 2008;27:S63–70.View ArticlePubMedGoogle Scholar
- Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:639–43.View ArticlePubMedGoogle Scholar
- Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352:1749–59.View ArticlePubMedGoogle Scholar
- Vlahos R, Bozinovski S, Gualano RC, Ernst M, Anderson GP. Modelling COPD in mice. Pulm Pharmacol Ther. 2006;19:12–7.View ArticlePubMedGoogle Scholar
- Wright JL, Churg A. Animal models of cigarette smoke-induced COPD. Chest. 2002;122:301S–6S.View ArticlePubMedGoogle Scholar
- Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, Enelow R, Elias JA. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest. 2008;118:2771–84.PubMedPubMed CentralGoogle Scholar
- Zhou Y, Kang MJ, Jha BK, Silverman RH, Lee CG, Elias JA. Role of ribonuclease L in viral pathogen-associated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling. J Immunol. 2013;191:2637–46.View ArticlePubMedPubMed CentralGoogle Scholar
- De Serres G, Lampron N, La Forge J, Rouleau I, Bourbeau J, Weiss K, Barret B, Boivin G. Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol. 2009;46:129–33.View ArticlePubMedGoogle Scholar
- Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1618–23.View ArticlePubMedGoogle Scholar
- Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370:786–96.View ArticlePubMedGoogle Scholar
- Mallia P, Johnston SL. Influenza infection and COPD. Int J Chron Obstruct Pulmon Dis. 2007;2:55–64.PubMedPubMed CentralGoogle Scholar
- Seagrave J, Barr EB, March TH, Nikula KJ. Effects of cigarette smoke exposure and cessation on inflammatory cells and matrix metalloproteinase activity in mice. Exp Lung Res. 2004;30:1–15.View ArticlePubMedGoogle Scholar
- Nyunoya T, March TH, Tesfaigzi Y, Seagrave J. Antioxidant diet protects against emphysema, but increases mortality in cigarette smoke-exposed mice. COPD. 2011;8:362–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Nikula KJ, March TH, Seagrave J, Finch G, Barr E, Menache M, Hahn F, Hobbs C. A mouse model of cigarette smoke-induced emphysema. Chest. 2000;117:246S–7S.View ArticlePubMedGoogle Scholar
- March TH, Wilder JA, Esparza DC, Cossey PY, Blair LF, Herrera LK, McDonald JD, Campen MJ, Mauderly JL, Seagrave J. Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. Toxicol Sci. 2006;92:545–59.View ArticlePubMedGoogle Scholar
- March TH, Bowen LE, Finch GL, Nikula KJ, Wayne BJ, Hobbs CH. Effects of strain and treatment with inhaled aII-trans-retinoic acid on cigarette smoke-induced pulmonary emphysema in mice. COPD. 2005;2:289–302.View ArticlePubMedGoogle Scholar
- Tate MD, Ioannidis LJ, Croker B, Brown LE, Brooks AG, Reading PC. The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One. 2011;6:e17618.View ArticlePubMedPubMed CentralGoogle Scholar
- Foronjy RF, Dabo AJ, Taggart CC, Weldon S, Geraghty P. Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice. PLoS One. 2014;9:e90567.View ArticlePubMedPubMed CentralGoogle Scholar
- Estripeaut D, Torres JP, Somers CS, Tagliabue C, Khokhar S, Bhoj VG, Grube SM, Wozniakowski A, Gomez AM, Ramilo O, et al. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J Infect Dis. 2008;198:1435–43.View ArticlePubMedPubMed CentralGoogle Scholar
- Tesfaigzi Y, McDonald JD, Reed MD, Singh SP, De Sanctis GT, Eynott PR, Hahn FF, Campen MJ, Mauderly JL. Low-level subchronic exposure to wood smoke exacerbates inflammatory responses in allergic rats. Toxicol Sci. 2005;88:505–13.View ArticlePubMedGoogle Scholar
- Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI, Ross TM, Witztum JL, Kolls JK. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol. 2009;183:5301–10.View ArticlePubMedPubMed CentralGoogle Scholar
- Sun S, Zhao G, Xiao W, Hu J, Guo Y, Yu H, Wu X, Tan Y, Zhou Y. Age-related sensitivity and pathological differences in infections by 2009 pandemic influenza A (H1N1) virus. Virol J. 2011;8:52.View ArticlePubMedPubMed CentralGoogle Scholar
- Ling MT, Tu W, Han Y, Mao H, Chong WP, Guan J, Liu M, Lam KT, Law HK, Peiris JS, et al. Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection. J Infect Dis. 2012;205:44–53.View ArticlePubMedGoogle Scholar
- van den Brand JM, Stittelaar KJ, van Amerongen G, Rimmelzwaan GF, Simon J, de Wit E, et al. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis. 2010;201:993–9.Google Scholar
- Lomo J, Blomhoff HK, Jacobsen SE, Krajewski S, Reed JC, Smeland EB. Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood. 1997;89:4415–24.PubMedGoogle Scholar
- Shi ZO, Fischer MJ, De Sanctis GT, Schuyler MR, Tesfaigzi Y. IFN-gamma, but not Fas, mediates reduction of allergen-induced mucous cell metaplasia by inducing apoptosis. J Immunol. 2002;168:4764–71.View ArticlePubMedGoogle Scholar
- Chen K, Pociask DA, McAleer JP, Chan YR, Alcorn JF, Kreindler JL, Keyser MR, Shapiro SD, Houghton AM, Kolls JK, Zheng M. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One. 2011;6:e20333.View ArticlePubMedPubMed CentralGoogle Scholar
- Hunninghake GM, Cho MH, Tesfaigzi Y, Soto-Quiros ME, Avila L, Lasky-Su J, Stidley C, Melen E, Soderhall C, Hallberg J, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med. 2009;361:2599–608.View ArticlePubMedPubMed CentralGoogle Scholar
- Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 1997;277:2002–4.View ArticlePubMedGoogle Scholar
- Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J. 2001;17:946–53.View ArticlePubMedGoogle Scholar
- Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol. 2003;28:555–62.View ArticlePubMedGoogle Scholar
- Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest. 2000;117:684–94.View ArticlePubMedGoogle Scholar
- Bauer CM, Zavitz CC, Botelho FM, Lambert KN, Brown EG, Mossman KL, Taylor JD, Stampfli MR. Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection. PLoS One. 2010;5:e13251.View ArticlePubMedPubMed CentralGoogle Scholar
- Hubeau C, Kubera JE, Masek-Hammerman K, Williams CM. Interleukin-6 neutralization alleviates pulmonary inflammation in mice exposed to cigarette smoke and poly(I:C). Clin Sci (Lond). 2013;125:483–93.View ArticleGoogle Scholar
- Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1304–9.View ArticlePubMedGoogle Scholar
- Maeno T, Houghton AM, Quintero PA, Grumelli S, Owen CA, Shapiro SD. CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol. 2007;178:8090–6.View ArticlePubMedGoogle Scholar
- Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485–517.View ArticlePubMedGoogle Scholar
- Khader SA, Gaffen SL, Kolls JK. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol. 2009;2:403–11.View ArticlePubMedPubMed CentralGoogle Scholar
- Brown DM, Lee S, Garcia-Hernandez Mde L, Swain SL. Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J Virol. 2012;86:6792–803.View ArticlePubMedPubMed CentralGoogle Scholar
- Bera MM, Lu B, Martin TR, Cui S, Rhein LM, Gerard C, Gerard NP. Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins. J Immunol. 2011;187:4245-55.Google Scholar
- Di Stefano A, Caramori G, Gnemmi I, Contoli M, Bristot L, Capelli A, Ricciardolo FL, Magno F, D’Anna SE, Zanini A, et al. Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD. Thorax. 2009;64:968–75.View ArticlePubMedGoogle Scholar
- Costa C, Rufino R, Traves SL, Lapa ESJR, Barnes PJ, Donnelly LE. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Chest. 2008;133:26–33.View ArticlePubMedGoogle Scholar
- D’Armiento JM, Scharf SM, Roth MD, Connett JE, Ghio A, Sternberg D, Goldin JG, Louis TA, Mao JT, O’Connor GT, et al. Eosinophil and T cell markers predict functional decline in COPD patients. Respir Res. 2009;10:113.View ArticlePubMedPubMed CentralGoogle Scholar
- Trojanek JB, Cobos-Correa A, Diemer S, Kormann M, Schubert SC, Zhou-Suckow Z, Agrawal R, Duerr J, Wagner CJ, Schatterny J, et al. Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema. Am J Respir Cell Mol Biol. 2014;51:709–20.View ArticlePubMedGoogle Scholar
- Tuder RM, Yun JH. It takes two to tango: cigarette smoke partners with viruses to promote emphysema. J Clin Invest. 2008;118:2689–93.PubMedPubMed CentralGoogle Scholar
- Lotz MT, Peebles Jr RS. Mechanisms of respiratory syncytial virus modulation of airway immune responses. Curr Allergy Asthma Rep. 2012;12:380–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hershenson MB, Lukacs NW. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol. 2011;179:248–58.View ArticlePubMedPubMed CentralGoogle Scholar
- Shi G, Vistica BP, Nugent LF, Tan C, Wawrousek EF, Klinman DM, Gery I. Differential involvement of Th1 and Th17 in pathogenic autoimmune processes triggered by different TLR ligands. J Immunol. 2013;191:415–23.View ArticlePubMedPubMed CentralGoogle Scholar
- Benwell RK, Lee DR. Essential and synergistic roles of IL1 and IL6 in human Th17 differentiation directed by TLR ligand-activated dendritic cells. Clin Immunol. 2010;134:178–87.View ArticlePubMedGoogle Scholar
- Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, Takeuchi O, Akira S. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med. 2006;203:1795–803.View ArticlePubMedPubMed CentralGoogle Scholar
- Hsia CC, Hyde DM, Ochs M, Weibel ER, Structure AEJTFoQAoL. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med. 2010;181:394–418.View ArticlePubMedGoogle Scholar
- Mitzner W. Use of mean airspace chord length to assess emphysema. J Appl Physiol (1985). 2008;105:1980–1.View ArticleGoogle Scholar
- Greaves IA, Colebatch HJ. Small airway pathology is related to increased closing capacity and abnormal slope of phase III in excised human lungs. Am Rev Respir Dis. 1980;122:657–9.PubMedGoogle Scholar
- Haber PS, Colebatch HJ, Ng CK, Greaves IA. Alveolar size as a determinant of pulmonary distensibility in mammalian lungs. J Appl Physiol Respir Environ Exerc Physiol. 1983;54:837–45.PubMedGoogle Scholar
- Yang QH, Lai-Fook SJ. Effect of lung inflation on regional lung expansion in supine and prone rabbits. J Appl Physiol (1985). 1991;71:76–82.Google Scholar